Preventive chemotherapy is the use of medicines, either alone or in combination, to prevent malaria infections and their consequences. It includes chemoprophylaxis, intermittent preventive treatment of infants (IPTi) and pregnant women (IPTp), seasonal malaria chemoprevention (SMC) and mass drug administration (MDA). These safe and cost-effective strategies are intended to complement ongoing malaria control activities, including vector control measures, prompt diagnosis of suspected malaria and treatment of confirmed cases with antimalarial medicines. In this article, we describe the chemoprphylaxis recommended for the special population groups. In addition, we also discuss the challenges and opportunities that lie ahead of us in order to tackle malaria.
Jishtu et al. (Mon,) studied this question.